Clinical Therapeutics Announces the Addition of Michael G. Spigarelli, MD, PhD, as Editor for a Refocused Pediatric, Adolescent, & Maternal Therapeutics Section
Posted on: Wednesday, 9 September 2009, 03:32 CDT
As section editor for the Pediatric, Adolescent, & Maternal Therapeutics
(http://www.clinicaltherapeutics.com/ped.html) section (formerly the
Pediatric Research section), Dr. Spigarelli brings a wealth of knowledge and
a strong background in addressing the issues surrounding these special
populations. He completed his residency in internal medicine and pediatrics
at the
Pregnant women and children remain among the most vulnerable patients undergoing therapy today due to a lack of critical information on the safety, tolerability, and efficacy of pharmacotherapies indicated for them. As Dr. Spigarelli states in his inaugural editorial, "To date, most medications used in the treatment of illness in children have never been tested in them.... This lack of crucial information has important implications for a variety of stakeholders."
By refocusing the Pediatric, Adolescent, & Maternal Therapeutics (http://www.clinicaltherapeutics.com/ped.html) section, Clinical Therapeutics(http://www.clinicaltherapeutics.com/) seeks to become the premier venue for publication of clinical research in these special populations and serve as an international forum for the timely discussion of safe and effective drug therapies in neonates, infants, children, adolescents, and pregnant or lactating women.
"As Editor of this section, I encourage each of you to review your files for data already obtained but not yet published, for data from ongoing studies, and consider submitting those manuscripts to Clinical Therapeutics. Each additional piece of available data adds to the knowledge base needed to provide the best health care for pregnant women and children."
An example of important pediatric information published by the journal is the supplemental issue on Conquering Pain: The Hidden Cost of Immunization sponsored by the Canadian Institutes of Health Research and the SickKids Foundation. Also highlighting the journal's commitment to fostering publication of scientific research related to these special populations is the upcoming focus issue on vaccines.
Articles can be submitted online or directly to clinther@elsevier.com; click here for Information for Authors (http://www.clinicaltherapeutics.com/ifa3.html).
For more information about this press release and Clinical Therapeutics,
contact
SOURCE Clinical Therapeutics
Source: PR Newswire
Related Articles
- Packard/Stanford Physician to Lead Society for Pediatric Research
- Discovery Labs KL-4 Surfactant Anti-Inflammatory Data Published in Pediatric Research
- Dell Pediatric Research Institute Receives $1 Million Gift From the Bank of America Charitable Foundation
- America's Top Pediatric Medical Institutions Unite to Drive Increased Federal Investment in Pediatric Research
- Analyse Therapeutic Clinical Intelligence - Rheumatoid Arthritis
- Collaboration to Create Pediatric Research Institute Receives $23 Million
- ViaCord and Children's Hospital Oakland Research Institute Announce 100th Cord Blood Transplant
- Alfacell Completes Non-Clinical Section of Rolling NDA for Lead Anticancer Drug ONCONASE(R)
- MedImmune Awards Fellowship Grants in Pediatric Research Totaling $210,000
- Fastlink Mobile Clinic for Children to Provide Free Dental Treatment and Other Health Services in Remote Areas
User Comments (0)

RSS Feeds